Table of Contents
Overview
New York, NY – June 17, 2025 – Global Peristaltic Pumps Market size is expected to be worth around US$ 3.2 Billion by 2034 from US$ 1.9 Billion in 2024, growing at a CAGR of 5.5% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 38.1% share with a revenue of US$ 0.7 Billion.
In 2024, the global peristaltic pumps market continues to gain momentum due to rising demand across pharmaceutical, food & beverage, and water treatment industries. These pumps operate by compressing a flexible tube to move fluids, ensuring contamination-free transfer and precise dosing. Their non-contact design makes them ideal for handling corrosive, viscous, and sterile liquids, especially in applications requiring high hygiene standards.
Pharmaceutical and biotechnology sectors are the leading end-users, leveraging peristaltic pumps for media transfer, sterile fluid handling, and vaccine production. According to the U.S. Food and Drug Administration (FDA), the adoption of single-use technologies has increased by over 20% since 2021, with peristaltic pumps playing a vital role in closed-loop systems. The food industry also benefits from these pumps, particularly for flavorings, dairy products, and high-viscosity sauces.
By type, the market is segmented into tube pumps and hose pumps, with tube pumps leading due to ease of use, compact design, and low maintenance. Geographically, North America dominates the market, while Asia Pacific is witnessing the fastest growth, supported by expanding manufacturing capabilities and regulatory improvements. With growing focus on automation, cleanroom production, and precise chemical metering, the peristaltic pumps market is projected to expand steadily through 2030, supported by technological advancements and global health infrastructure upgrades.
Key Takeaways
- Market Size: In 2023, the global peristaltic pumps market was valued at US$ 1.9 billion and is projected to reach US$ 3.2 billion by 2033, growing at a CAGR of 5.5% during the forecast period.
- By Pressure Type: The market is segmented into tube pumps and hose pumps, with tube pumps leading the segment in 2023, accounting for a 56.4% share due to their compact design and ease of operation.
- By Discharge Capacity: The discharge category includes five segments: up to 30 psi, 31 to 50 psi, 51 to 100 psi, 101 to 150 psi, and above 150 psi. The up to 30 psi segment held a notable share of 14.7% in 2023.
- By End User: The market is segmented into pharmaceutical & medical, water & wastewater, pulp & paper, food & beverage, and others. Among these, the pharmaceutical & medical sector dominated with a 53.5% share, owing to increasing adoption in sterile fluid transfer and bioprocessing.
- By Region: North America emerged as the leading regional market, capturing 38.1% of the total revenue share in 2023, supported by strong pharmaceutical manufacturing and advanced healthcare infrastructure.
Segmentation Analysis
- Pressure Analysis: In 2023, the tube pump segment led with a 56.4% market share, driven by its ability to deliver contamination-free, precise fluid handling. These pumps are essential in pharmaceutical and food applications due to their gentle fluid transfer and easy maintenance. As demand rises for automated and sterile processes, especially in sensitive industries, the adoption of tube pumps is expected to grow steadily, supported by their accuracy, durability, and operational efficiency.
- Discharge Analysis: Peristaltic pumps with discharge capacities up to 30 psi accounted for 41.7% of the market in 2023. This dominance is due to increasing use in labs, pharmaceuticals, and food processing where low pressure is sufficient. These systems are cost-effective and support compact, efficient operations. The trend toward precision and low-pressure fluid handling continues to gain momentum, particularly in sensitive environments, further reinforcing the growth prospects for this segment in the near term.
- End-User Analysis: The pharmaceutical & medical sector dominated in 2023 with a 53.5% revenue share, owing to rising demand for sterile and precise fluid transfer. Peristaltic pumps are favored for drug manufacturing, diagnostic systems, and patient care due to their contamination-free operation. With global healthcare needs increasing and the prevalence of chronic diseases and surgeries rising, this segment is expected to expand further as manufacturers seek reliable and efficient fluid management systems.
Market Segments
By Pressure
- Tube Pump
- Hose Pump
By Discharge
- Up to 30 psi
- Above 150 psi
- 51 to 100 psi
- 31 to 50 psi
- 101 to 150 psi
By End-user
- Pharmaceutical & Medical
- Water & Wastewater
- Pulp & Paper
- Food & Beverage
- Others
Regional Analysis
In 2023, North America led the global peristaltic pumps market with a 38.1% revenue share, driven by strong adoption across pharmaceuticals, water treatment, and food processing sectors. The U.S. Food and Drug Administration approved 15% more new drug applications compared to 2022, boosting demand for sterile fluid handling in pharmaceutical manufacturing.
Federal funding for water infrastructure projects reached US$ 7 billion, as reported by the U.S. Environmental Protection Agency, accelerating the use of peristaltic pumps in wastewater treatment. Additionally, a 6% rise in food safety compliance inspections prompted food manufacturers to adopt hygienic pumping systems. Biopharmaceutical production capacity in the U.S. grew by 8%, and automation in chemical processing rose by 10%, further supporting market growth.
Asia Pacific is projected to record the highest CAGR during the forecast period. China approved 22% more pharmaceutical production facilities in 2023, while India mandated a 30% increase in effluent treatment plants. Japan reported a 12% rise in biopharmaceutical exports, and Australia registered an 18% increase in medical device manufacturers. Southeast Asian countries invested US$3.5 billion in water treatment, reinforcing demand for peristaltic pumps across pharmaceutical, industrial, and environmental sectors.
Emerging Trends
- Miniaturization for Microfluidics: The development of peristaltic micropumps has accelerated, driven by the demand for compact, precise fluid control in lab on a chip and point of care devices. Recent reviews highlight progress in reducing pump size while maintaining accurate flow rates as low as microliters per minute.
- Integration in Medical Infusion Systems: Peristaltic mechanisms have become standard in infusion and dialysis devices due to their sterility and gentle handling of biological fluids. FDA guidance notes that peristaltic pumps are classified as Class II medical devices and are widely employed in multi‐channel infusion pumps for controlled drug delivery.
- Adoption in Environmental Sampling: Low flow and low stress sampling techniques have increased reliance on peristaltic pumps for groundwater monitoring. EPA protocols recommend their use for sampling at depths up to 25 feet, ensuring minimal disturbance of volatile compounds during collection.
Use Cases
- Groundwater Monitoring and Sampling: In environmental fieldwork, peristaltic pumps enable low flow purging of monitoring wells where depth to water is less than 25 feet. This technique is specified in EPA Region 4 guidance to reduce sample disturbance and volatile loss during volatile organic compound (VOC) analysis.
- Drinking Water Chemical Dosing: Among the 148,457 active public water systems in the U.S. (2020 data), many facilities employ peristaltic pumps to dose disinfectants such as chlorine and fluoride. The precise, metered delivery capabilities of these pumps support compliance with national drinking water standards.
- Hemodialysis Machines: Nearly 808,000 people in the U.S. were living with end stage kidney disease in 2020, of whom 69% approximately 558,000 patients—received dialysis treatments. Hemodialysis devices rely on peristaltic pumps capable of flow rates from 5 mL/min to 300 mL/min to circulate blood through dialyzers while maintaining sterile, pulsation controlled flow.
- Bioreactor Volume Control in Research: In CDC bioreactor test stands, peristaltic pumps are used downstream of reactors to fine tune outlet flow rates. By operating at rates as low as 0.1 mL/min, these pumps ensure precise volume control during microbial and biofilm studies, enhancing experimental reproducibility.
Conclusion
The global peristaltic pumps market is positioned for sustained growth, driven by rising demand in pharmaceuticals, water treatment, food processing, and environmental monitoring. The market benefits from the pumps’ precision, sterility, and non-contact fluid handling, which are essential for regulatory compliance and process efficiency.
North America leads in adoption, while Asia Pacific is witnessing the fastest growth due to infrastructure investments and pharmaceutical expansion. Emerging trends such as microfluidic integration, medical device usage, and environmental sampling further enhance market relevance. Technological advancements and expanding end-user applications will continue to drive the market through the forecast period.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
